Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)
Palomino Laboratories recorded quarterly Accounts Payables of $55687.0 in Q4 2025, down 8.64% quarter-over-quarter from $60952.0 in Q3 2025, and up 1592.1% year-over-year from $3291.0 in Q4 2024.
Palomino Laboratories' Accounts Payables history runs 4 years deep, the most recent figure standing at $55687.0 for Q4 2025.
- In Q4 2025, Accounts Payables rose 1592.1% year-over-year to $55687.0; the TTM figure through Dec 2025 stood at $55687.0 (up 1592.1% YoY), while the FY2025 annual figure was $55687.0, up 1592.1% from the prior year.
- Accounts Payables came in at $55687.0 for Q4 2025 at Palomino Laboratories, down from $60952.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $60952.0 in Q3 2025 to a low of $58.0 in Q4 2023.
- A 4-year average of $35037.1 and a median of $43954.0 in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 99.54% in 2023 and surged 5574.14% in 2024, its largest moves.
- Palomino Laboratories' Accounts Payables stood at $12500.0 in 2022, then sank by 99.54% to $58.0 in 2023, then soared by 5574.14% to $3291.0 in 2024, then soared by 1592.1% to $55687.0 in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $55687.0, $60952.0, and $40781.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,687.00 |
| Sep 30, 2025 | 60,952.00 |
| Jun 30, 2025 | 40,781.00 |
| Mar 31, 2025 | 45,816.00 |
| Dec 31, 2024 | 3,291.00 |
| Sep 30, 2024 | 46,757.00 |
| Jun 30, 2024 | 43,954.00 |
| Mar 31, 2024 | 47,112.00 |
| Dec 31, 2023 | 58.00 |
| Sep 30, 2023 | 28,500.00 |
| Dec 31, 2022 | 12,500.00 |